Retinal disease in Rpe65-deficient mice: Comparison to human leber congenital amaurosis due to RPE65 mutations

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5304-5313

  Caruso, Rafael C ^a   Aleman, Tomas S ^a   Cideciyan, Artur V ^a   Roman, Alejandro J ^a   Sumaroka, Alexander ^a   Mullins, Cristina L ^a   Boye, Sanford L ^b   Hauswirth, William W ^b   Jacobson, Samuel G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B WAVE; CELL ACTIVATION; CELL FUNCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ELECTRORETINOGRAM; GENE; GENE MUTATION; HUMAN; HUMAN CELL; ILLUMINATION; LEBER CONGENITAL AMAUROSIS; LIGHT INTENSITY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR CELL; PHOTOSTIMULATION; PHOTOTRANSDUCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA DISEASE; RPE65 GENE; SCHOOL CHILD; TOPOGRAPHY; VISUAL IMPAIRMENT; WAVEFORM; AGING; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DARK ADAPTATION; ELECTRORETINOGRAPHY; GENETICS; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DEGENERATION; TIME; VISION;

CARRIER PROTEIN; EYE PROTEIN; RPE65 PROTEIN, HUMAN; RPE65 PROTEIN, MOUSE;

ADOLESCENT; ADULT; AGING; ANIMALS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DARK ADAPTATION; ELECTRORETINOGRAPHY; EYE PROTEINS; HUMANS; LEBER CONGENITAL AMAUROSIS; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUTATION; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DEGENERATION; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISION, OCULAR;

EID: 77958121723     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5559     Document Type: Article

References (73)

1. Stone EM. Leber congenital amaurosis-a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144:791-811.
2. den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27:391-419.
3. AV. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res. 2010;29: 398-427.
4. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
5. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
6. Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short term results of a phase I trial. Hum Gene Ther. 2008;19:979-990.
7. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA. 2008;105: 15112-15117.
8. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102: 6177-6182.
9. Jacobson SG, Cideciyan AV, Aleman TS, et al. Photoreceptor layer topography in children with Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2008; 49:4573-4577.
10. Jacobson SG, Aleman TS, Cideciyan AV, et al. Defining the residual vision in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50:2368-2375.
11. Redmond TM, Yu S, Lee E, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20: 344-351.
12. Aleman TS, LaVail MM, Montemayor R, et al. Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vision Res. 2001;41: 2779-2797.
13. Roman AJ, Boye SL, Aleman TS, et al. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis. Mol Vis. 2007;13:1701-1710.
14. Cideciyan AV, Jacobson SG. An alternative phototransduction model for human rod and cone ERG a-waves: normal parameters and variation with age. Vision Res. 1996;36:2609-2621.
15. Cideciyan AV. In vivo assessment of photoreceptor function in human diseases caused by photoreceptor-specific gene mutations. Methods Enzymol. 2000;316:611-626.
16. Van Hooser JP, Aleman TS, He YG, et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA. 2000;97:8623-8628.
17. Dejneka NS, Surace EM, Aleman TS, et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther. 2004;9:182-188.
18. Lamb TD, Pugh EN Jr. Phototransduction, dark adaptation, and rhodopsin regeneration: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47:5137-5152.
19. Hood DC, Birch DG. A computational model of the amplitude and implicit time of the b-wave of the human ERG. Vis Neurosci. 1992;8:107-126.
20. Jacobson SG, Aleman TS, Cideciyan AV, et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci USA. 2007;104:15123-15128.
21. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405-2416.
22. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073-1078.
23. Aleman TS, Cideciyan AV, Sumaroka A, et al. Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations. Invest Ophthalmol Vis Sci. 2008;49:1580-1590.
24. Jacobson SG, Cideciyan AV, Sumaroka A, et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci. 2006;47:4113-4120.
25. Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci. 2007;48:4759-4765.
26. Drasdo N, Millican CL, Katholi CR, Curcio CA. The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field. Vision Res. 2007;47: 2901-2911.
27. Li C, Cheng M, Yang H, Peachey NS, Naash MI. Age-related changes in the mouse outer retina. Optom Vis Sci. 2001;78:425-430.
28. Gresh J, Goletz PW, Crouch RK, Rohrer B. Structure-function analysis of rods and cones in juvenile, adult, and aged C57bl/6 and Balb/c. Vis Neurosci. 2003;20:211-220.
29. Williams GA, Jacobs GH. Cone-based vision in the aging mouse. Vision Res. 2007;47:2037-2046.
30. Ablonczy Z, Crouch RK, Goletz PW, et al. 11-cis-Retinal reduces constitutive opsin phosphorylation and improves quantum catch in retinoid-deficient mouse rod photoreceptors. J Biol Chem. 2002;277:40491-40498.
31. Fan J, Rohrer B, Moiseyev G, Ma JX, Crouch RK. Isorhodopsin rather than rhodopsin mediates rod function in RPE65 knock-out mice. Proc Natl Acad Sci USA. 2003;100:13662-13667.
32. Woodruff ML, Wang Z, Chung HY, Redmond TM, Fain GL, Lem J. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat Genet. 2003;35:158-164.
33. Gouras P, Kong J, Tsang SH. Retinal degeneration and RPE transplantation in Rpe65([1]/[1]) mice. Invest Ophthalmol Vis Sci. 2002; 43:3307-3311.
34. Rohrer B, Goletz P, Znoiko S, et al. Correlation of regenerable opsin with rod ERG signal in Rpe65[1]/[1] mice during development and aging. Invest Ophthalmol Vis Sci. 2003;44:310-315.
35. Fan J, Woodruff ML, Cilluffo MC, Crouch RK, Fain GL. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice. J Physiol. 2005;568:83-95.
36. Samardzija M, von Lintig J, Tanimoto N, et al. R91W mutation in Rpe65 leads to milder early onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Hum Mol Genet. 2008; 17:281-292.
37. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
38. Carter-Dawson LD, LaVail MM. Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy. J Comp Neurol. 1979;188(2):245-262.
39. Jeon C-J, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci. 1998;18:8936-8946.
40. Van Hooser JP, Liang Y, Maeda T, et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J Biol Chem. 2002;277:19173-19182.
41. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res. 1998;17:485-521.
42. Weymouth AE, Vingrys AJ. Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog Retin Eye Res. 2008;27:1-44.
43. Banin E, Cideciyan AV, Aleman TS, et al. Retinal rod photoreceptor- specific gene mutation perturbs cone pathway development. Neuron. 1999;23:549-557.
44. Jacobson SG, Sumaroka A, Aleman TS, Cideciyan AV, Danciger M, Farber DB. Evidence for retinal remodeling in retinitis pigmentosa caused by PDE6B mutation. Br J Ophthalmol. 2007;91:699-701.
45. Cideciyan AV, Aleman TS, Jacobson SG, et al. Centrosomal-ciliary gene CEP290/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis. Hum Mut. 2007;28:1074-1083.
46. Jacobson SG, Aleman TS, Cideciyan AV, et al. Leber congenital amaurosis caused by Lebercilin (LCA5) mutation: retained photoreceptors adjacent to retinal disorganization. Mol Vis. 2009;15: 1098-1106.
47. -/- mice. Invest Ophthalmol Vis Sci. 2009;50:4368-4378.
48. Pugh EN Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta. 1993;1141: 111-149.
49. Pugh EN Jr, Falsini B, Lyubarsky AL. The origin of the major rodand cone-driven components of the rodent electroretinogram, and the effect of age and light-rearing history on the magnitudes of these components. In: Williams TP, Thistle AB, eds. Photostasis and Related Topics. New York: Plenum; 1998;93-128.
50. Cideciyan AV, Jacobson SG. Negative electroretinograms in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1993;34:3253-3263.
51. Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci. 1994;35:2948-2961.
52. Goto Y, Peachey NS, Ziroli NE, et al. Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci Vis. 1996;13:577-585.
53. Fan J, Sakurai K, Chen CK, et al. Deletion of GRK1 causes retina degeneration through a transducin-independent mechanism. J Neurosci. 2010;30:2496-2503.
54. Leskov IB, Klenchin VA, Handy JW, et al. The gain of rod phototransduction: reconciliation of biochemical and electrophysiological measurements. Neuron. 2000;27:525-537.
55. Lyubarsky AL, Falsini B, Pennesi ME, Valentini P, Pugh EN Jr. UVand midwave-sensitive cone-driven retinal responses of the mouse: a possible phenotype for coexpression of cone photopigments. J Neurosci. 1999;19:442-455.
56. -/- mouse at early ages. Invest Ophthalmol Vis Sci. 2005;46:1473-1479.
57. -/- mice: a defect that can be corrected by 11-cis retinal. Invest Ophthalmol Vis Sci. 2005;46:3876-3882.
58. Zhang H, Fan J, Li S, et al. Trafficking of membrane-associated proteins to cone photoreceptor outer segments requires the chromophore 11-cis-retinal. J Neurosci. 2008;28:4008-4014.
59. -/- mice: comparable models of Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2008;49:2384-2389.
60. Moiseyev G, Crouch RK, Goletz P, Oatis J Jr., Redmond TM, Ma JX. Retinyl esters are the substrate for isomerohydrolase. Biochemistry. 2003;42:2229-2238.
61. Qtaishat NM, Redmond TM, Pepperberg DR. Acute radiolabeling of retinoids in eye tissues of normal and rpe65-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:1435-1446.
62. Maeda A, Maeda T, Imanishi Y, Golczak M, Moise AR, Palczewski K. Aberrant metabolites in mouse models of congenital blinding diseases: formation and storage of retinyl esters. Biochemistry. 2006;45:4210-4219.
63. Batten ML, Imanishi Y, Maeda T, et al. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J Biol Chem. 2004;279:10422-10432.
64. Paunescu K, Wabbels B, Preising MN, Lorenz B. Longitudinal and cross-sectional study of patients with early onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol. 2005;243:417-426.
65. Jacobson SG, Cideciyan AV, Aleman TS, et al. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. Hum Mol Genet. 2008;17:2405-2415.
66. Dinculescu A, Glushakova L, Min SH, Hauswirth WW. Adenoassociated virus-vectored gene therapy for retinal disease. Hum Gene Ther. 2005;16:649-663.
67. Yáñez-Muñoz RJ, Balaggan KS, MacNeil A, et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med. 2006;12: 348-353.
68. Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med. 2008; 10:375-382.
69. Petrs-Silva H, Dinculescu A, Li Q, et al. High efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther. 2008;17:463-471.
70. Farjo R, Skaggs J, Quiambao AB, Cooper MJ, Naash MI. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One. 2006;1:e38.
71. Dalkara D, Kolstad KD, Caporale N, et al. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009;17:2096-2102.
72. Rotenstreich Y, Harats D, Shaish A, Pras E, Michael B. Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis betacarotene. Br J Ophthalmol. 2010;94(5):616-621.
73. Nusinowitz S, Ridder WH 3rd, Pang JJ, et al. Cortical visual function in the rd12 mouse model of Leber congenital amaurosis (LCA) after gene therapy replacement therapy to restore retinal function. Vision Res. 2006;46:3926-3934.